Anti-CTAg Antibodies Identified in Stage I, II Melanoma
Specific antibodies against three tumor antigens identified as promising diagnostic biomarkers for early-stage melanomas
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.